Screener
Eligibility screening
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial C…
3 US sites in CA, OH, UT
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.